Skip to content

Nicole Martinez-Martin, a postdoctoral fellow in biomedical ethics, shares her experiences in the realms of teaching, law, and health in this In the Spotlight Q&A.

Nicole Martinez-Martin, a postdoctoral fellow in biomedical ethics, shares her experiences in the realms of teaching, law, and health in this In the Spotlight Q&A.

In this Stanford Medicine Unplugged post, medical student Steven Zhang reflects on the importance of remembering that a patient is more than their "numbers."

In this Stanford Medicine Unplugged post, medical student Steven Zhang reflects on the importance of remembering that a patient is more than their "numbers."

Published on

A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.

A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.

A new algorithm helps turn veterinary notes into systemic codes, a development that could help track disease and enable drug trials.

A new algorithm helps turn veterinary notes into systemic codes, a development that could help track disease and enable drug trials.

Published on

Stanford chemists have developed a potential new strategy for fighting antibiotic-resistant bacterium — adding a new molecule onto an existing antibiotic.

Stanford chemists have developed a potential new strategy for fighting antibiotic-resistant bacterium — adding a new molecule onto an existing antibiotic.

Published on

Studies have associated low zinc levels with autism spectrum disorder. But why this should be the case has been unclear. Now, scientists may have an explanation for the link.

Studies have associated low zinc levels with autism spectrum disorder. But why this should be the case has been unclear. Now, scientists may have an explanation for the link.

Published on

Genetic mutations affecting a single gene called LRRK2 play an outsized role in Parkinson's disease, but nobody's been able to say what the connection is between the genetic defect and the brain-cell die-off that characterizes the condition. Here's a clue.

Genetic mutations affecting a single gene called LRRK2 play an outsized role in Parkinson's disease, but nobody's been able to say what the connection is between the genetic defect and the brain-cell die-off that characterizes the condition. Here's a clue.

Published on

In this piece, Dean Lloyd Minor argues that doctors and researchers have a responsibility to educate people about the role and value of science.

In this piece, Dean Lloyd Minor argues that doctors and researchers have a responsibility to educate people about the role and value of science.

Published on

Stanford study finds the lifespan of people over the age of 65 in developed countries is steadily increasing and is showing no signs of slowing down.

Stanford study finds the lifespan of people over the age of 65 in developed countries is steadily increasing and is showing no signs of slowing down.

During a talk at Stanford, journalist and author Barry Meier discussed his nearly two-decade long investigation into OxyContin and Purdue Pharma.

During a talk at Stanford, journalist and author Barry Meier discussed his nearly two-decade long investigation into OxyContin and Purdue Pharma.

What will the future of FAST, the science education program led by Stanford graduate students, look like? Will its benefits extend beyond San Jose?

What will the future of FAST, the science education program led by Stanford graduate students, look like? Will its benefits extend beyond San Jose?

Published on

In this final piece in the Understanding AFib series, physician Randall Stafford offers evidence-based advice for remaining healthy with the condition.

In this final piece in the Understanding AFib series, physician Randall Stafford offers evidence-based advice for remaining healthy with the condition.

Stanford researchers have shown in rats that pharmacologically active amounts of a fast-acting anesthetic drug could be released from nanoparticle "cages" in small, specified brain areas at which the scientists had aimed a beam of focused ultrasound. In principle, the same approach could work for many drugs with widely differing pharmacological actions and psychiatric applications, and even for some chemotherapeutic drugs used to combat cancer.

Stanford researchers have shown in rats that pharmacologically active amounts of a fast-acting anesthetic drug could be released from nanoparticle "cages" in small, specified brain areas at which the scientists had aimed a beam of focused ultrasound. In principle, the same approach could work for many drugs with widely differing pharmacological actions and psychiatric applications, and even for some chemotherapeutic drugs used to combat cancer.

Published on